Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Nov 01, 2010 (Vol. 30, No. 19)

geneimprint

URL:www.geneimprint.com/site/home
  • Well organized, links to current journal articles
  • Nothing significant

Genomic imprinting gurus, unite! …And then go visit geneimprint.com, a genomic imprinting oasis from the Jirtle Laboratory at Duke University. Whether you want an introduction to this phenomenon of parent-of-origin dependent gene silencing or you are looking for some timely scientific literature on the topic, geneimprint provides answers to your queries. There is a “featured research” page, as well as an archive of select imprinting scientific articles, arranged by year. (Yes, there are articles from the current year.) If the article archive isn’t current enough for you, the “hot off the press” page provides a daily listing of the most recent imprinting and epigenetics journal articles. Beyond simply presenting links to current literature, the website also includes a species-specific listing of imprinted genes, as well as a list of links to other imprinting resources.

  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »